Guangzhou Wellman New Drug Development Center

Guangzhou Wellman New Drug Development Center is a specialized biotechnology research organization based in Guangzhou, China, dedicated to the discovery and development of novel small molecule drugs. The center focuses on high-impact therapeutic areas such as anti-infectives, cardiovascular health, and metabolic disorders. With a strong emphasis on intellectual property and early-stage R&D, the company advances candidates through the preclinical pipeline and into early clinical trials. It serves as a key player in the regional biotech ecosystem, often collaborating with academic and industrial partners to bring innovative treatments to market. The center's research portfolio includes several proprietary compounds aimed at addressing unmet medical needs in the Chinese and global markets.